No Data
Kangzhi Pharmaceutical: Report for the third quarter of 2024
Honz Pharmaceutical (300086.SZ): Currently, the company has a business of importing active pharmaceutical ingredients.
Gelonghui on September 27th | Honz Pharmaceutical (300086.SZ) stated on the investor interaction platform that the company currently has a business of importing active pharmaceutical ingredients. In order to benefit from the relevant policies of Hainan Free Trade Port, the company has applied for and obtained the 'AEO Advanced Certified Enterprise Certificate'. Enterprises certified by AEO can carry out mutual recognition cooperation with customs of various countries, achieve credit management of enterprises in global customs, enjoy preferential treatment provided by global customs, which will promote the company's cooperation and development in foreign trade.
Honz Pharmaceutical Logs About 30 Million Yuan in Damages Amid Typhoon Makar; Shares Up 20%
Honz pharmaceutical (300086.SZ): Expected to suffer asset losses of approximately 30 million yuan due to the impact of typhoon disaster.
Gelonghui, September 11th | Honz Pharmaceutical (300086.SZ) announced that on September 6, 2024, Hainan was hit by the 11th super typhoon 'Capricorn' this year. The company's production base in Haikou, Hainan, suffered losses to some assets due to the combined effects of this typhoon and heavy rain. As of the disclosure date of the announcement, the company's resumption of work is progressing in an orderly manner. Currently, the company's inventory is adequate, and this disaster does not currently affect the company's normal supply and sales. However, due to damage to factories, machinery, and equipment, there is a certain impact on the normal production of the company's workshop. Due to network issues.
Express News | Honz Pharmaceutical: Estimated losses from typhoon disaster of 30 million yuan.
Honz Pharmaceutical: Half-year report for the year 2024.
No Data
No Data